• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6例慢性复发性艰难梭菌腹泻患者的细菌疗法

Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

作者信息

Tvede M, Rask-Madsen J

机构信息

Department of Clinical Microbiology, Rigshospitalet, Statens Seruminstitut, Denmark.

出版信息

Lancet. 1989 May 27;1(8648):1156-60. doi: 10.1016/s0140-6736(89)92749-9.

DOI:10.1016/s0140-6736(89)92749-9
PMID:2566734
Abstract

Six patients with chronic relapsing diarrhoea caused by Clostridium difficile were treated with rectal instillation of homologous faeces (one patient) or a mixture of ten different facultatively aerobic and anaerobic bacteria diluted in sterile saline (five patients). The mixture led to a prompt loss of Cl difficile and its toxin from the stools and to bowel colonisation by Bacteroides sp, which had not been present in pre-treatment stool samples. Strains of Escherichia coli, Cl bifermentans, and Peptostreptococcus productus in the mixture inhibited the in-vitro growth of Cl difficile, which in turn inhibited the growth of Bacteroides ovatus, Bacteroides vulgatus, and Bacteroides thetaiotaomicron. The finding that Bacteroides sp had been absent during the patients' illness but was present after recovery suggests that the absence of Bacteroides sp may result in chronic relapsing Cl difficile diarrhoea, and that its presence may prevent colonisation by Cl difficile.

摘要

6例由艰难梭菌引起的慢性复发性腹泻患者接受了以下治疗:1例患者采用同源粪便直肠滴注,5例患者采用在无菌盐水中稀释的10种不同兼性需氧菌和厌氧菌的混合物。该混合物导致粪便中艰难梭菌及其毒素迅速消失,并使拟杆菌属在肠道定植,而这些拟杆菌在治疗前的粪便样本中并不存在。混合物中的大肠杆菌、双发酵梭菌和产肽链球菌菌株抑制了艰难梭菌的体外生长,而艰难梭菌又反过来抑制了卵形拟杆菌、普通拟杆菌和多形拟杆菌的生长。患者患病期间不存在拟杆菌属但康复后存在这一发现表明,拟杆菌属的缺失可能导致慢性复发性艰难梭菌腹泻,而其存在可能阻止艰难梭菌定植。

相似文献

1
Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.6例慢性复发性艰难梭菌腹泻患者的细菌疗法
Lancet. 1989 May 27;1(8648):1156-60. doi: 10.1016/s0140-6736(89)92749-9.
2
Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012.直肠细菌疗法治疗复发性艰难梭菌相关性腹泻:2000-2012 年丹麦 55 例患者的病例系列研究结果。
Clin Microbiol Infect. 2015 Jan;21(1):48-53. doi: 10.1016/j.cmi.2014.07.003. Epub 2014 Oct 12.
3
Bacteriotherapy for Clostridium difficile diarrhoea.艰难梭菌腹泻的细菌疗法
Lancet. 1989 Sep 2;2(8662):558. doi: 10.1016/s0140-6736(89)90674-0.
4
Clostridium difficile in association with sporadic diarrhoea.艰难梭菌与散发性腹泻相关。
Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):230-3. doi: 10.1136/bmj.284.6311.230.
5
Fecal bacteriotherapy for recurrent Clostridium difficile infection.粪便细菌疗法治疗复发性艰难梭菌感染。
Anaerobe. 2009 Dec;15(6):285-9. doi: 10.1016/j.anaerobe.2009.09.007. Epub 2009 Sep 22.
6
Recurrent Clostridium difficile infection treated with home fecal transplantation: a case report.家庭粪便移植治疗复发性艰难梭菌感染:一例报告
J Med Case Rep. 2014 Nov 28;8:393. doi: 10.1186/1752-1947-8-393.
7
Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients.32例复发性艰难梭菌相关性腹泻患者的粪便移植治疗
Scand J Gastroenterol. 2012 May;47(5):548-52. doi: 10.3109/00365521.2012.672587. Epub 2012 Apr 2.
8
Bile salt hydrolase-mediated inhibitory effect of Bacteroides ovatus on growth of Clostridium difficile.卵形拟杆菌胆汁盐水解酶对艰难梭菌生长的抑制作用。
J Microbiol. 2017 Nov;55(11):892-899. doi: 10.1007/s12275-017-7340-4. Epub 2017 Oct 27.
9
Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease?艰难梭菌相关性腹泻:在炎症性肠病中起作用?
Lancet. 1980 Feb 23;1(8165):383-4. doi: 10.1016/s0140-6736(80)90940-x.
10
Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection.人类粪便中主要细菌群落随年龄及艰难梭菌感染的变化
J Med Microbiol. 2002 May;51(5):448-454. doi: 10.1099/0022-1317-51-5-448.

引用本文的文献

1
Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in infection (CDI), asymptomatic carriage and non-CDI diarrhea.宏基因组分析揭示了感染性(艰难梭菌感染)、无症状携带和非艰难梭菌感染性腹泻中具有多样化功能的肠道微生物群特征的不同模式。
Gut Microbes. 2025 Dec;17(1):2505269. doi: 10.1080/19490976.2025.2505269. Epub 2025 May 14.
2
Fecal microbiota transplantation: a tale of two regulatory pathways.粪便微生物群移植:两条监管途径的故事
Gut Microbes. 2025 Dec;17(1):2493901. doi: 10.1080/19490976.2025.2493901. Epub 2025 Apr 29.
3
Impact of Probiotics and Prebiotics on Gut Microbiome and Hormonal Regulation.
益生菌和益生元对肠道微生物群及激素调节的影响
Gastrointest Disord (Basel). 2024 Dec;6(4):801-815. doi: 10.3390/gidisord6040056. Epub 2024 Sep 27.
4
Fecal Microbiota Transplantation: Indications, Methods, and Challenges.粪便微生物群移植:适应症、方法及挑战
J Microbiol. 2024 Dec;62(12):1057-1074. doi: 10.1007/s12275-024-00184-3. Epub 2024 Nov 18.
5
Microbes as medicine.微生物作为药物。
Ann N Y Acad Sci. 2024 Nov;1541(1):63-82. doi: 10.1111/nyas.15237. Epub 2024 Oct 11.
6
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection.用于预防艰难梭菌感染的活体生物治疗产品的合理设计
J Infect Dis. 2024 Sep 24. doi: 10.1093/infdis/jiae470.
7
Rational Design of Live Biotherapeutic Products for the Prevention of Infection.用于预防感染的活体生物治疗产品的合理设计。
bioRxiv. 2024 May 2:2024.04.30.591969. doi: 10.1101/2024.04.30.591969.
8
Exploring the relationship between and in inflammatory bowel disease (IBD): Insights and implications.探索炎症性肠病(IBD)中[具体内容缺失]与[具体内容缺失]之间的关系:见解与启示。
Comput Struct Biotechnol J. 2023 Nov 19;23:1-9. doi: 10.1016/j.csbj.2023.11.027. eCollection 2024 Dec.
9
Microbiome Contributions to Health.微生物组对健康的贡献。
Surg Infect (Larchmt). 2023 Apr;24(3):213-219. doi: 10.1089/sur.2023.002.
10
Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends.过去十年的粪便微生物群移植研究:现状与趋势
Can J Infect Dis Med Microbiol. 2023 Jan 9;2023:6981721. doi: 10.1155/2023/6981721. eCollection 2023.